he etiologic cause of Kawasaki disease (KD) remains unknown and research is ongoing. To date, there has not been reproducible evidence implicating a specific infectious agent. Positive serology for Yersinia pseudotuberculosis was reported in 10% of KD patients in Hiroshima, Japan 1 and adenoviral infection was frequently associated with KD in 2 outbreaks in Japan. 2 Since the first case report of concomitant dengue fever and KD in the English literature, 3 there has been a report of the relationship of KD and dengue fever by Tourneux et al, 4 and a recent report of a similar infant case by Mekmullica et al, 5 raising several possibilities, including the concept that the dengue virus may be a potential etiological cause of KD and that Aedes (A.) mosquitoes may transmit the causative agent of KD, together with the dengue virus. Dengue viral infection of human umbilical cord vein leads to production of chemokines, such as interleukin (IL)-6 and IL-8, 6 complement activation, and apoptosis. 7 Dengue viral infection also induces cell proliferation and morphological changes of human endothelial cells and potentially cause arteritis, including coronary arteritis, which is the hallmark of KD. Myocarditis is reported in KD patients, 8, 9 as well as in dengue cases. 10 Several non-invasive cardiac investigations, such as tissue Doppler imaging 11 and signal-averaged electrocardiography, 11 have been used to identify myocardial oxidative stress and damage in KD patients. A preliminary study at Songklanagarind Hospital, Prince of Songkla University, was conducted to find the relation of dengue viral infection by positive serologic criteria with the diagnosis of KD in children.
Methods
All medical records of children with KD diagnosed between January 2002 and December 2005 in Songklanagarind Hospital were reviewed. The diagnosis of KD and the definition of coronary artery lesions were based on the report of the Research Committee on Kawasaki Disease. 13, 14 Dengue IgM and hemagglutination inhibition (HI) titers were obtained at the time of diagnosis of KD and a second dengue HI titer was obtained 2-3 weeks later. Positive dengue IgM ≥40 units or a 4-fold rising HI titer indicates dengue viral infection according to the WHO serologic criteria. 15 Informed consent for inclusion in the study was given by the parents. Echocardiographic studies were done in all patients and all received intravenous immunoglobulin (IVIG) ranging from 1 to 1.5 g/kg (average 1.24 g/kg), in combination with continuing high-dose aspirin (80-100 mg·kg -1 ·day -1 ) until the patient was afebrile for 4 days. We used IVIG (Venoglobulin S ® then Flebogamma ® ) from the same company (Grifols Thailand) during the study period of 4 years.
Results
During the 4-year study period, a total of 65 pediatric patients were diagnosed with KD and 90% had typical or complete KD. After IVIG administration and high-dose aspirin, 62 patients had clinical improvement in 24-48 h and of them 48 had complete serologic studies of dengue viral infection, from which 9 (18.7%) were diagnosed as having serologically proved dengue viral infection, but had presented with KD without clinical or laboratory findings of dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS) ( Table 1) .
The ratio of males to females was 2:1 (6 and 3 cases, 
Discussion
DHF is an endemic disease in the South-East Asian, Western Pacific and American regions of the WHO, with a potential for epidemic disease ignited by imported DHF cases in many countries, including the United States and Japan, 16 because of the presence of the vector, A. albopictus (Part of this concept was published as short note in Dengue Bulletin 17 and the map of the distribution of A. albopictus in the United States, by county, is available on the CDC web page).
The most important vectors transmitting dengue viruses are A. aegypti and A. albopictus. 18, 19 In addition, A. polynesiensis and other members of the subgenus Stegomyia transmit dengue in restricted geographical areas. 20 A. albopictus, which adapts well to cold climate and survives year round, is endemic in the US and Japan, whereas both A. aegypti and A. albopictus are present in South-East Asia, including Taiwan. A. aegypti infected with dengue viruses may temporarily be transported by air or ship into Japan and the US and survive during the summer, with the possibility of domestic transmission by A. albopictus. These mosquitoes normally feed on a single vertebrate host, but a small percentage of each of the 2 species feed on more than 1 host during 1 gonotrophic cycle 21 and that multiple-feeding behavior is of epidemiological significance. Despite the fact that the vectors can travel up to 2.5 km daily in an open environment, a study in Africa found that only 0.7% of mosquitoes visited more than 4 houses. 22 However, a study from India showed that most A. aegypti were found indoors, 23 indicating the endophilic nature of the species. In contrast, A. albopictus is exophilic (outdoor habitat). These dengue vectors may potentially cause epidemics of DHF/DSS in Japan and the US, and possibly carry the causative agent of KD.
The seasonal distribution of KD cases in winter and spring in the USA 24 and Japan, together with the results from a recent study by Burns et al, 25 may be partly explained by the changing habitat pattern of A. albopictus from exophilic to endophilic for survival during periods of low temperature and therefore spreading the possible infective agents responsible for KD.
Our study at Songklanagarind Hospital revealed that 9 of 48 patients (18.7%) with clinically and echocardiographically proven KD had primary (7 cases) or secondary dengue viral infection (2 cases). None of the reported cases of KD with positive dengue titer had clinical manifestations of DF/DHF. This finding may be partly explained by the effect of IVIG on the course of DHF/DSS in which immunologic response is pathogenetic. Thrombocytopenia may not be present because of thrombocytosis in KD patients. Furthermore, primary dengue infection has no effect on thrombocytopenia, as shown in the 7 of 9 patients with positive dengue IgM. These patients presented as KD, which may have been triggered by the dengue infection.
There is concern that IVIG administration interfered with the dengue titer study in the present patients; however, this is most unlikely as commercial IVIG is prepared from pooled serum. Data from the IVIG company states that this pooled serum for IVIG is from donors in USA where DF is not endemic and only imported cases have been reported. Therefore, because we used the same lots of IVIG it is unlikely to have caused a 4-fold rise in the dengue titer (HI titer). Also, an elevated IgM dengue titer did not interfere with IVIG in 7 of 9 cases. Our finding is significant and needs a further prospective multicenter study with large numbers of KD patients to evaluate the relationship of serologic evidence of dengue viral infection in children diagnosed with KD, at least in South-East Asia. To date, a total of 12 KD cases have been reported with positive dengue serologic titers proving dengue infection (Table 2 ).
